The Effect of Kinesiophobia on Physical Activity, Balance and Falling in Parkinson's Disease Patients

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 40 to 85 years
• All sexes
• No healthy volunteers
• Adult, Older adult

Study population: The population of the study consisted of patients with Parkinson's disease who were in 1-3 stages according to Hoehn-Yahr Scale. The sample consisted of 60 patients who applied to Istanbul University Cerrahpaşa Medical Faculty Neurology Department Movement Disorders Unit, complied with the inclusion criteria, read the information form and signed an informed consent form.

Trial locations and contacts

1 site in 1 country.

About this study

Conditions

Parkinson Disease, Kinesiophobia, Physical Activity, Balance, Falling

Being tested

Tampa Kinesiophobia Scale, Berg-Balance Test, International Physical Activity Questionnaire-Short Form, Falls Efficacy Scale

Keywords

Parkinson's Disease, Kinesiophobia, Physical Activity, Balance, Falling

Medical subject headings

Parkinson Disease, Kinesiophobia, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Tampa Kinesiophobia Scale, Berg-Balance Test, International Physical Activity Questionnaire-Short Form, Falls Efficacy ScaleOther

  Tampa Kinesiophobia Scale: The TSK is a 17-item self report checklist using a 4-point Likert scale that was developed as a measure of fear of movement or (re)injury.

  Berg-Balance Test: 14-item scale designed to measure balance of the older adult in a clinical setting.

  International Physical Activity Questionnaire-Short Form: This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting.

  Falls Efficacy Scale: A 16- item self-administered questionnaire designed to assess fear of falling in mainly older population

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Tampa Kinesiophobia Scale (TSK)

   It is a 17-item self report checklist using a 4-point Likert scale

   Measured: 10 minutes

2. Berg-Balance Test

   14-item scale designed to measure balance of the older adult in a clinical setting. Scoring: A five-point ordinal scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function. Total Score = 56 41-56 = low fall risk 21-40 = medium fall risk 0 -20 = high fall risk

   Measured: 15-20 minutes

3. Falls Efficacy Scale

   It is a 10 item scale where each item is rated on a scale of 1-10. A score of 10 signifies no confidence in these activities; a score of 1 indicates confidence. Out of a total score of 100, a score of 70 or above indicates the individual has a fear of falling.

   Measured: 5-7 minutes

4. International Physical Activity Questionnaire - Short form

   This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. Walking = 3.3 METs Moderate Intensity = 4.0 METs Vigorous Intensity = 8.0 METs Total MET-minutes/week = Walk (METs*min*days) + Mod (METs*min*days) + Vig (METs*min*days)

   1. Low: • No activity is reported OR • Some activity is reported but not enough to meet Categories 2 or 3. 2. Moderate: • 3 or more days of vigorous activity of at least 20 minutes per day OR • 5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day OR • 5 or more days of any combination of walking, moderate-intensity or vigorousintensity activities achieving a minimum of at least 600 MET-minutes/week. 3. High: • Vigorous-intensity activity on at least 3 days and accumulating at least 1500 MET-minutes/week OR • 7 or more days of any combination of walki

   Measured: 5-10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted1 Feb 2019
2. Study start1 Apr 2018
3. Primary completion1 Apr 2019
4. Study completion1 Oct 2019

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.